Traina, F., Costa, F. F., Machado-Neto, J. A., Andreoli-Risso, M. F., De Mello Campos, P., & Olalla Saad, S. T. Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome.
Chicago Style (17th ed.) CitationTraina, F., F. F. Costa, J. A. Machado-Neto, M. F. Andreoli-Risso, P. De Mello Campos, and S. T. Olalla Saad. Lack of Association Between MDM2 SNP309 and TP53 Arg72Pro Polymorphisms with Clinical Outcomes in Myelodysplastic Syndrome.
MLA (9th ed.) CitationTraina, F., et al. Lack of Association Between MDM2 SNP309 and TP53 Arg72Pro Polymorphisms with Clinical Outcomes in Myelodysplastic Syndrome.
Warning: These citations may not always be 100% accurate.


